How Low Is The SARS-CoV-2 Mortality Rate?

We All Grew Up With Coronaviruses, As Did All Our Ancestors. To understand the relevance of mortality rate, you have to appreciate that coronaviruses first became pathogenic to humans in the range 12,000 – 10,000 years ago, as a consequence of the first interaction between humans and livestock that occurred in the early Holocene. Mankind […]

Read More…


Antiphospholipid Antibodies And COVID-19 Vaccines.

Background. As early as October 2020 – over ten months ago – we explained why a vaccine was not needed and would not be effective. That’s a vaccine using its correct medical definition, i.e. a prophylactic treatment providing long-term or lifetime protection. All of the four main treatment candidates being injected – Vaxzevria; BNT126b2; mRNA-1273 […]

Read More…




UK Deaths Increase By Over One Third Since Vaccine Rollout.

UK Deaths Increase By More Than One Third Since Vaccine Rollout. In the four weeks since the ‘vaccine’ rollout, UK COVID-19 deaths have risen by 31,368 (source: Johns Hopkins Coronavirus Resource Center and Worldmeters, @0500UTC 18/02/21). As the ‘vaccine’ is being offered to those in high risk groups first, it does not follow that over […]

Read More…


Nitric Oxide Immunity In The Upper Respiratory Tract.

The Upper Respiratory Tract Is The Key Battleground. Back in July 2020, we first explained the crucial significance of vitamin D as an effective viral countermeasure as well as the significance of vitamin D deficiency in SARS-CoV-2’s pathogenesis and COVID-19 disease severity. Then in October we highlighted the importance of the vitamin D→endothelial nitric oxide synthase→nitric […]

Read More…


Antibody-Dependent Enhancement And This Rushed ‘Vaccine’.

What is Antibody-Dependent Enhancement? As we have set out previously, it takes 10-15 years to develop a vaccine. This timescale is entirely understandable and justifiable when you consider that the vaccine has to be both effective and safe. Safe includes not causing unacceptable side effects, which include the vaccine or immune system’s response triggering autoimmunity, […]

Read More…


Exoribonuclease – Your Starter For Ten Mr Prime Minister.

Q1. How can a virus containing an exoribonuclease mutate in the way you are saying? Coronaviruses possess an exoribonuclease within nonstructural protein 14 (nsp14-ExoN). This functions as a proofreader during viral transcription and encoding, ensuring high fidelity replication. This minimises the potential for mutation, as shown by the fact that sarbecovirus/lineage B betacoronaviruses with their […]

Read More…



The Common Cold And SARS-CoV-2 Immunity.

No Vaccine Required. Is it possible that the common cold could can provide immunity through memory T cells to a significant proportion of a population? In recent articles we have highlighted various other reasons why a vaccine is not required. This include; those not at risk (that’s over 99%) don’t need one and those at […]

Read More…